Brief: Prime Medicine And Cimeio Therapeutics Announce Research Collaboration To Develop Prime Edited Shielded-Cell & Immunotherapy Pairs
22/06/2023 13:20
June 22 (Reuters) - Prime Medicine Inc PRME.O :
* PRIME MEDICINE INC: CO, CIMEIO THERAPEUTICS ANNOUNCE
RESEARCH
COLLABORATION TO DEVELOP PRIME EDITED SHIELDED-CELL &
IMMUNOTHERAPY PAIRS
Source text for Eikon: ID:nGNX8mMCTk
Further company coverage: PRME.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Prime Medicine
See all newsBrief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm647 In Alpha-1 Antitrypsin Deficiency
Prime Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Prime Medicine Q2 net loss narrows on lower expenses
Brief: Prime Medicine, Inc. Q2 EPS USD -0.24
Brief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm577a In H1069q-Mutated Wilson Disease